Navigation Links
China Medicine Renews Contract with CCG Investor Relations
Date:1/5/2009

GUANGZHOU, China, Jan. 5 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, medical devices and medical formulations, announced today that it has renewed its contract with CCG Investor Relations for a primary term of one year commencing on January 1, 2009.

"After one year of service, we are happy to renew our contract and have CCG Investor Relations continue to design and execute our investor relations campaign," said Mr. Senshan Yang, Chief Executive Officer of China Medicine. "We are looking forward to utilizing CCG's full set of services to further raise our visibility in the investment community and support the rollout of recombinant Aflatoxin Detoxifizyme (rADTZ), our innovative product that has the potential to detoxify aflatoxin (AFT), a potential cancer causing agent, in food and feed."

China Medicine operates through its 100%-owned subsidiary, Guangzhou Konzern Pharmaceutical Company Ltd. ("Konzern"). In addition to maintaining its status as a leading distributor of pharmaceuticals in China, the Company has transformed itself into an innovative developer of Chinese pharmaceuticals and proprietary formulas. After the success of a reverse merger of Konzern into a public shell company in 2006, the Company ventured into research and development by establishing Guangzhou Co-win Bioengineering Co., Ltd. with Guangzhou Ji'nan Science & Technology Industrial Group and Mr. Dongsheng Yao, in which the Company, through Konzern, owns 70% equity interest. The rADTZ project has received a government grant and will continue to receive financial support from the government as one of "863" key projects starting commercialization after more than ten years of research and incubation.


'/>"/>
SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 03, 2015 Dan E. Chambers, ... a special focus on capital crimes, recently spoke on the ... murder trial. The hosts of the Independent Journal Review radio ... history working first as a prosecutor and now as a ... the decisions made in the trial and sentencing of this ...
(Date:3/3/2015)... Dallas, TX (PRWEB) March 04, 2015 ... comprehensive information on the therapeutic development for Alopecia. Alopecia ... alopecia are the two main types of alopecia. Causes ... autoimmune disorder. Symptoms of alopecia may include male pattern ... and broken hair. Alopecia can be classified as focal ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The first ... the National Sleep Foundation. The event brings recognition to ... over. , According to the Centers for ... problems of one form or another. Too little or ... risk of physical illness and depression, and even a ...
(Date:3/3/2015)... OH (PRWEB) March 03, 2015 ... to better predict antidepressant treatment outcomes for patients ... resources, than any of the individual genes that ... by investigators from the Mayo Clinic and Assurex ... i. , The proprietary technology of the ...
(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...
Breaking Medicine News(10 mins):Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3
... In a study that seems to pivot on a paradox, ... stimulant as an immune system suppressor to treat a common, ... cancer patients. The effect, in some cases, was profound. ... issue of the New England Journal of Medicine , ...
... Maureen Salamon HealthDay Reporter , WEDNESDAY, Nov. 30 ... with women and men facing different heart risks even when ... study suggests. Analyzing the results of coronary CT angiographies ... in 480 patients with acute chest pain, scientists from the ...
... ARBOR, Mich. As cancer researchers continue to ... are also creating a catalog of possible targets ... Michigan Comprehensive Cancer Center and Michigan Center for ... aimed at solving the practical challenges involved in ...
... that an inflammatory mechanism known as inflammasome may lead ... as a heart attack, pointing researchers toward developing more ... Following a heart attack, an inflammatory process occurs in ... nutrients. This process helps the heart to heal, but ...
... News) -- Toddlers who take anti-HIV drugs have higher cholesterol ... study shows. It,s the first such finding in toddlers ... National Institutes of Health researchers and colleagues. They reviewed ... to HIV in the womb. Of the 83 who were ...
... led by the University of Kentucky researcher Elaine Wittenberg-Lyles ... themselves and require their own unique care needs. ... Qualitative Health Research , assessed the individual stressors that ... and the intervention team. The caregivers were asked to ...
Cached Medicine News:Health News:New approach to graft-versus-host treatment results in improvement for some patients 2Health News:New approach to graft-versus-host treatment results in improvement for some patients 3Health News:New approach to graft-versus-host treatment results in improvement for some patients 4Health News:Clogged Arteries Pose Different Dangers for Men, Women: Study 2Health News:Clogged Arteries Pose Different Dangers for Men, Women: Study 3Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 2Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 3Health News:Researchers examine role of inflammatory mechanisms in a healing heart 2Health News:Toddlers Taking HIV Drugs Have Higher Cholesterol 2Health News:Study shows hospice caregivers need routine care interventions 2
(Date:3/3/2015)... /CNW/ - The issue: Health ... injected at Art Nails Ltd., located at 751 Helmcken St., ... it contained no labelling. All products administered by injection in ... must have approved labelling. The store owner ... Potential risks associated with injecting an unauthorized version of a health ...
(Date:3/3/2015)...  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) ... engaged in the design, development and production of ... medical device companies has announced the acquisition of ... medical cable manufacturer based in North Carolina.  The ... the name MTI Medical Cables.  ...
(Date:3/3/2015)... Mass. , March 3, 2015  Web ... and manufacturing services in the Medical Device, Advanced ... has been named a 3M Medical Specialties Preferred ... new status will allow companies to streamline their ... point of contact for 3M materials, intermediate converting ...
Breaking Medicine Technology:Advisory - Health product seized from Art Nails in Vancouver 2American Biosurgical Acquires MTI Corporation 2Web Industries Receives 3M Preferred Converter Status 2
...   Seminars: February 14-15, 2012 ,Exhibition: February ... largest packaging tradeshow, announced the launch of two new ... 14-16, 2012. The seminars focus on sustainability and automation ... impacting all sectors of the packaging industry. ...
... Inc. (OTC: PLCSF), a company focused on innovative medical ... patient in the CIN-RG trial, the company,s pivotal trial ... RenalGuard System™ in the prevention of Contrast-Induced Nephropathy (CIN).  ... secure regulatory approval by the U.S. Food and Drug ...
Cached Medicine Technology:WestPack Launches New Sustainability and Automation and Cost Control Seminars 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
A Color-Enhanced Slide Agglutination Test for the Rapid Qualitative and Semi-Quantitative Detection of Rheumatoid Factor in Serum....
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
Medicine Products: